Zoetis Revenue 2011-2018 | ZTS

Current and historical revenue for Zoetis (ZTS) from 2011 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities. Zoetis revenue for the twelve months ending June 30, 2018 was $5.588B. Zoetis revenue for the three months ending June 30, 2018 was $1.415B, representing a 11.51% increase from the same quarter last year.
Zoetis Annual Revenue
(Millions of US $)
2017 $5,307
2016 $4,888
2015 $4,765
2014 $4,785
2013 $4,561
2012 $4,336
2011 $4,233
2010 $3,582
Zoetis Quarterly Revenue
(Millions of US $)
Q2 2018 $1,415
Q1 2018 $1,366
Q4 2017 $1,460
Q3 2017 $1,347
Q2 2017 $1,269
Q1 2017 $1,231
Q4 2016 $1,277
Q3 2016 $1,241
Q2 2016 $1,208
Q1 2016 $1,162
Q4 2015 $1,274
Q3 2015 $1,214
Q2 2015 $1,175
Q1 2015 $1,102
Q4 2014 $1,320
Q3 2014 $1,210
Q2 2014 $1,158
Q1 2014 $1,097
Q4 2013 $1,254
Q3 2013 $1,103
Q2 2013 $1,114
Q1 2013 $1,090
Q4 2012 $1,176
Q3 2012 $1,019
Q2 2012 $1,094
Q1 2012 $1,047
Q4 2011 $0
Q4 2010 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $44.024B $5.307B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.408B 10.89
Grifols (GRFS) Spain $14.128B 18.31
Jazz Pharmaceuticals (JAZZ) Ireland $10.650B 15.67
Neurocrine Biosciences (NBIX) United States $10.514B 0.00
Nektar Therapeutics (NKTR) United States $10.415B 12.18
Sage Therapeutics (SAGE) United States $7.008B 0.00
Ionis Pharmaceuticals (IONS) United States $7.004B 0.00
Catalent (CTLT) United States $5.388B 25.09
United Therapeutics (UTHR) United States $5.372B 6.90
FibroGen (FGEN) United States $5.111B 0.00
Loxo Oncology (LOXO) United States $4.865B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.186B 16.21
Madrigal Pharmaceuticals (MDGL) United States $3.640B 0.00
Endo (ENDP) Ireland $3.605B 5.18
USANA Health Sciences (USNA) United States $3.143B 27.69
Heron Therapeutics (HRTX) United States $3.078B 0.00
Aerie Pharmaceuticals (AERI) United States $2.973B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.887B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.434B 0.00
Xencor (XNCR) United States $2.289B 0.00
Tilray (TLRY) United States $2.226B 0.00
PTC Therapeutics (PTCT) United States $2.097B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.917B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.744B 21.32
Zogenix (ZGNX) United States $1.741B 0.00
Portola Pharmaceuticals (PTLA) United States $1.733B 0.00
Impax Laboratories (AMRX) United States $1.636B 35.16
TESARO (TSRO) United States $1.540B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.515B 0.00
Corcept Therapeutics (CORT) United States $1.447B 22.27
Arrowhead Pharmaceuticals (ARWR) United States $1.439B 0.00
ImmunoGen (IMGN) United States $1.374B 0.00
TherapeuticsMD (TXMD) United States $1.271B 0.00
Esperion Therapeutics (ESPR) United States $1.262B 0.00
Endocyte (ECYT) United States $1.145B 0.00
Karyopharm Therapeutics (KPTI) United States $1.121B 0.00
Tricida (TCDA) United States $1.001B 0.00
Radius Health (RDUS) United States $0.963B 0.00
Flexion Therapeutics (FLXN) United States $0.863B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.770B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.705B 0.00
CASI Pharmaceuticals (CASI) United States $0.680B 0.00
ArQule (ARQL) United States $0.655B 0.00
GlycoMimetics (GLYC) United States $0.644B 0.00
Siga Technologies (SIGA) United States $0.644B 0.00
Dova Pharmaceuticals (DOVA) United States $0.641B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.591B 0.00
Collegium Pharmaceutical (COLL) United States $0.574B 0.00
ChemoCentryx (CCXI) United States $0.555B 33.21
OptiNose (OPTN) United States $0.526B 0.00
Lannett Co Inc (LCI) United States $0.515B 4.74
Odonate Therapeutics (ODT) United States $0.510B 0.00
Majesco Entertainment (COOL) United States $0.508B 0.00
Aclaris Therapeutics (ACRS) United States $0.504B 0.00
Xeris Pharmaceuticals (XERS) United States $0.494B 0.00
Translate Bio (TBIO) United States $0.476B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.459B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.448B 0.00
Akebia Therapeutics (AKBA) United States $0.447B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.439B 0.00
Forty Seven (FTSV) United States $0.434B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.416B 0.00
Dermira (DERM) United States $0.407B 0.00
Aquestive Therapeutics (AQST) United States $0.405B 0.00
Concert Pharmaceuticals (CNCE) United States $0.392B 0.00
ElectroCore (ECOR) United States $0.387B 0.00
Mast Therapeutics (SVRA) United States $0.371B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.364B 24.86
Neon Therapeutics (NTGN) United States $0.338B 0.00
Minerva Neurosciences (NERV) United States $0.326B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.297B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.277B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.277B 0.00
Opexa Therapeutics (ACER) United States $0.270B 0.00
Zafgen (ZFGN) United States $0.264B 0.00
Achaogen (AKAO) United States $0.255B 0.00
Jounce Therapeutics (JNCE) United States $0.247B 0.00
Aratana Therapeutics (PETX) United States $0.245B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.243B 0.00
Ocular Therapeutix (OCUL) United States $0.242B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.236B 0.00
Tyme Technologies (TYME) United States $0.232B 0.00
IMV INC (IMV) Canada $0.226B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.222B 0.00
DURECT (DRRX) United States $0.212B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.203B 0.00
Adherex Technologies (FENC) United States $0.196B 0.00
Ardelyx (ARDX) United States $0.195B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.185B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
MediWound (MDWD) Israel $0.179B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.178B 0.00
Neos Therapeutics (NEOS) United States $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 0.00
Calithera Biosciences (CALA) United States $0.171B 0.00
Cardiome Pharma (CORV) Canada $0.168B 0.00
Galectin Therapeutics (GALT) United States $0.167B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.164B 0.00
Immune Design (IMDZ) United States $0.164B 0.00
ContraFect (CFRX) United States $0.160B 0.00
Aldeyra Therapeutics (ALDX) United States $0.158B 0.00
Melinta Therapeutics (MLNT) United States $0.147B 0.00
ProNAi Therapeutics (SRRA) Canada $0.145B 0.00
Molecular Templates (MTEM) United States $0.141B 0.00
KalVista Pharmaceuticals (KALV) United States $0.141B 0.00
Forward Pharma (FWP) Denmark $0.136B 0.00
MEI Pharma (MEIP) United States $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.128B 0.00
SteadyMed (STDY) Israel $0.126B 0.00
Recro Pharma (REPH) United States $0.123B 0.00
Iterum Therapeutics (ITRM) Ireland $0.120B 0.00
Infinity Pharmaceuticals (INFI) United States $0.118B 0.00
CTI BioPharma (CTIC) United States $0.113B 0.00
Rafael Holdings (RFL) United States $0.113B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.112B 0.00
Otonomy (OTIC) United States $0.098B 0.00
BioLineRx (BLRX) Israel $0.095B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Affimed (AFMD) Germany $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 0.00
Champions Oncology (CSBR) United States $0.086B 0.00
Natural Alternatives (NAII) United States $0.074B 9.51
KemPharm (KMPH) United States $0.073B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.071B 0.00
Trillium Therapeutics (TRIL) Canada $0.069B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.068B 0.00
Novan (NOVN) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.063B 0.00
Genocea Biosciences (GNCA) United States $0.054B 0.00
Capnia (SLNO) United States $0.053B 0.00
Mannatechorporated (MTEX) United States $0.050B 26.33
Tokai Pharmaceuticals (NVUS) United States $0.049B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.045B 37.67
Heat Biologics (HTBX) United States $0.042B 0.00
Avenue Therapeutics (ATXI) United States $0.039B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.038B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.92
Matinas Biopharma Holdings (MTNB) United States $0.034B 0.00
Biomerica (BMRA) United States $0.033B 0.00
Xenetic Biosciences (XBIO) United States $0.033B 0.00
IsoRay (ISR) United States $0.032B 0.00
Lipocine (LPCN) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.031B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.031B 0.00
Onconova Therapeutics (ONTX) United States $0.031B 0.00
HANCOCK JAFFE (HJLI) United States $0.029B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.029B 0.00
Regulus Therapeutics (RGLS) United States $0.028B 0.00
Shineco (TYHT) China $0.025B 2.15
XTL Biopharmaceuticals (XTLB) Israel $0.024B 0.00
NanoViricides (NNVC) United States $0.024B 0.00
Can-Fite Biopharma (CANF) Israel $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
Aradigm (ARDM) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
Midatech Pharma (MTP) United Kingdom $0.017B 0.00
Egalet (EGLT) United States $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Skyline Medical (AIPT) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
PharmAthene (ALT) United States $0.013B 0.00
India Globalization Capital (IGC) United States $0.012B 0.00
Intellipharmaceutics (IPCI) Canada $0.012B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.008B 0.00
Pain Therapeutics (PTIE) United States $0.008B 0.00
RXi Pharmaceuticals (RXII) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.006B 0.00
Biostar Pharmaceuticals (BSPM) China $0.005B 2.86
Aralez Pharmaceuticals (ARLZ) Canada $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00